What Does Reistone Biopharma Do?

Total employees150
HeadquartersShanghai
Founded2015

Reistone Biopharma is a clinical-stage biopharmaceutical company focused on developing novel medicines for autoimmune and inflammatory diseases. With a mission to address unmet medical needs, Reistone leverages its global research and development capabilities to advance a pipeline of innovative therapies. The company integrates discovery, development, and commercialization efforts, with a strong emphasis on scientific rigor and patient outcomes.

Where Is Reistone Biopharma's Headquarters?

HQ Function

Serves as the global research and development hub, overseeing drug discovery, preclinical research, early clinical development, and corporate strategy for the China region.

Notable Features:

Located in Zhangjiang Hi-Tech Park, a leading life sciences cluster, featuring modern laboratory and office spaces designed for collaborative research and innovation.

Work Culture:

A dynamic and innovative environment focused on scientific excellence, patient-centricity, and collaborative teamwork to advance biopharmaceutical breakthroughs. Emphasis on global standards and agile R&D processes.

HQ Significance:

The Shanghai headquarters is pivotal for Reistone's global R&D pipeline, driving innovation from discovery to early clinical phases and leveraging the rich talent pool and infrastructure of the Zhangjiang biotech ecosystem.

Values Reflected in HQ: The HQ's location in a premier science park and its advanced facilities reflect Reistone's commitment to cutting-edge science, innovation, global collaboration, and attracting top talent.

Location:

Reistone Biopharma supports its R&D and clinical operations globally, with primary centers in China (Shanghai and Beijing) and the United States (Greater Boston Area). The company conducts multinational clinical trials and aims to bring its innovative therapies for autoimmune and inflammatory diseases to patients worldwide by collaborating with international partners and regulatory agencies.

Street Address:

Building 10, Lane 666, Gaoke Middle Road, Zhangjiang Hi-Tech Park, Pudong New Area

City:

Shanghai

State/Province:

Shanghai

Country:

China

Where Else Does Reistone Biopharma Operate Around the World?

Framingham, Massachusetts, USA

Address: 200 Staples Drive, Suite 201, Framingham, MA 01702, USA

To advance Reistone's clinical pipeline in the United States, engage with regulatory authorities like the FDA, and foster partnerships within the North American biopharma ecosystem.

Beijing, China

Address: Room 1601-1603, Block B, Topliš-China World Office Building, No. 1 Jianguomenwai Avenue, Chaoyang District, Beijing, China 100004

To manage and execute clinical trials effectively in China, navigate the local regulatory landscape, and prepare for potential commercialization of approved therapies in the region.

Buying Intent Signals for Reistone Biopharma

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Reistone Biopharma? Meet the Executive Team

As of April 2025, Reistone Biopharma' leadership includes:

Min Zhang, Ph.D. - Co-founder, CEO
Aik Hong Tan, M.D. - Chief Medical Officer
Qiang Lu, Ph.D. - Chief Technology Officer
Iris Wang, Ph.D. - Chief Business Officer
Xiaowen He, M.D. - VP, Head of Clinical Operations China

Who's Investing in Reistone Biopharma?

Reistone Biopharma has been backed by several prominent investors over the years, including:

CPE
GSNV (Granite Hill Capital Partners)
TF Capital
Re-UpDragged Ventures
Loyal Valley Capital

What Leadership Changes Has Reistone Biopharma Seen Recently?

Hire1
Exits0

In the past 12 months, Reistone Biopharma has strengthened its executive leadership, notably with the appointment of a new Chief Medical Officer to spearhead its global clinical development strategies. Publicly available information does not indicate major executive departures during this period.

New Appointments:

Dr. Aik Hong Tan, Reistone Biopharma appointed Dr. Aik Hong Tan as its new Chief Medical Officer to oversee global clinical strategy and development for its pipeline candidates.

What Technology (Tech Stack) Is Used byReistone Biopharma?

Discover the tools Reistone Biopharma uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Reistone Biopharma Email Formats and Examples

Reistone Biopharma likely utilizes common corporate email formats based on employee names and their domain 'reistonebio.com'. While not publicly confirmed, patterns such as [firstinitial][lastname] or [firstname].[lastname] are standard.

[firstinitial][lastname]@reistonebio.com

Format

mzhang@reistonebio.com

Example

85%

Success rate

What's the Latest News About Reistone Biopharma?

PR Newswire / Company Website • February 26, 2024

Reistone Biopharma Appoints Dr. Aik Hong Tan as Chief Medical Officer

Reistone Biopharma announced the appointment of Dr. Aik Hong Tan as its Chief Medical Officer. Dr. Tan will be responsible for leading the global clinical strategy and development of the company's innovative pipeline....more

Company Website • July 12, 2023

Reistone Biopharma Announces First Patient Dosed in Phase II Clinical Trial of SHR0302 for Atopic Dermatitis in China

Reistone Biopharma announced that the first patient has been dosed in its Phase II clinical trial of SHR0302 (ivarmacitinib), a highly selective JAK1 inhibitor, for the treatment of moderate-to-severe atopic dermatitis (AD) in China....more

Company Website / PR Newswire • March 20, 2023

Reistone Biopharma's Partner Kaken Pharmaceutical Obtains Manufacturing and Marketing Approval in Japan for EBGLYSS® (lebrikizumab) for Atopic Dermatitis

Reistone Biopharma's partner, Kaken Pharmaceutical Co., Ltd., announced that it has obtained manufacturing and marketing approval in Japan for EBGLYSS® for subcutaneous injection (lebrikizumab), an anti-IL-13 monoclonal antibody, for the treatment of atopic dermatitis. Reistone has the rights to develop and commercialize lebrikizumab in Greater China....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Reistone Biopharma, are just a search away.